Log in
Enquire now
‌

US Patent 9061031 Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy

Patent 9061031 was granted and assigned to Bluebird Bio on June, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Bluebird Bio
Bluebird Bio
Current Assignee
Bluebird Bio
Bluebird Bio
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9061031
Patent Inventor Names
Mitchell Howard Finer0
Gabor Veres0
Julian Down0
Maria Joann Denaro0
Date of Patent
June 23, 2015
Patent Application Number
14488058
Date Filed
September 16, 2014
Patent Primary Examiner
‌
Robert M Kelly
Patent abstract

The present invention provides compositions comprising retroviral vectors, transduced cells, and methods of using the same for gene therapy. In particular, the present invention relates to lentiviral vectors and cells transduced with those vectors to provide gene therapy to subjects having an adrenoleukodystrophy and/or adrenomyeloneuropathy.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9061031 Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us